Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

NCT07407803 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

177

Enrollment

INDUSTRY

Sponsor class

Conditions

Plexiform Neurofibroma

Interventions

DRUG: TQ-B3234 capsules
DRUG: TQ-B3234 placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.